Newmont Corporation (NEM)
Quantitative Summary
DeterministicAt 14.2x earnings — a 61% discount to the sector average of 36.7x — NEM is in the lower valuation range. Financial health metrics are strong: Piotroski 9/9, Altman Z 4.7 (above 3.0 safe zone threshold). DCF fair value of $351 implies 201% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Newmont Corporation display a stark dichotomy between operational efficiency and profitability quality. While the company generates an attractive ROIC-WACC spread of 10.6%, indicating strong value creation potential, this is driven almost entirely by leverage rather than organic margin expansion or asset utilization; the DuPont decomposition reveals that equity returns are fueled by an Equity Multiplier of 1.68x while Net Margins sit at a modest 31.2% and Asset Turnover remains low at 0.40x. Despite these structural constraints, creditworthiness appears robust with a high Altman Z-Score of 4.6 and a pristine Piotroski F-Score of 9/9, suggesting minimal financial distress risk and strong balance sheet health. However, the Profitability Factor (RMW) registers at -1.401, signaling that despite current earnings quality metrics, the firm is underperforming its sector peers on profitability trends relative to size and age.
Valuation metrics present a significant divergence between traditional multiples and intrinsic value models. The stock trades at 17.8x forward earnings, substantially below the Basic Materials sector average of 41.0x, reflecting market skepticism regarding growth prospects rather than fundamental weakness. This discount is quantified by a DCF model implying substantial upside to $408 per share, representing a calculated 277.1% premium over current levels based on specific cash flow assumptions. Yet, this valuation thesis relies heavily on aggressive growth expectations that contradict the implied free cash flow trajectory; a ten-year projected FCF growth rate of -2.3% suggests the DCF inputs assume a turnaround in capital intensity or pricing power not yet reflected in historical revenue dynamics where YoY growth was 21.3%.
Risk-adjusted performance indicators reveal conflicting signals regarding future alpha generation. The stock has historically delivered exceptional risk premiums, evidenced by an annual Fama-French Alpha of 101.05% and a positive Value Factor tilt of 0.392, yet the negative Profitability Factor indicates these returns may be decoupled from sustainable earnings power. Compounding this uncertainty is recent insider activity showing $1,978,315 in net selling over the last ninety days, which often precedes further downside if management anticipates deteriorating fundamentals or capital allocation challenges. The confluence of deep valuation discounts against a backdrop of weak profitability trends and insider distribution creates an environment where the mathematical case for significant upside hinges entirely on the validity of the assumed cash flow reversion.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 21% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 6% | 7.8% | 9.8% |
|---|---|---|---|
| 2% | $446 | $298 | $217 |
| 3% | $580 | $351 | $243 |
| 4% | $848 | $432 | $278 |
Center = base case. Green = >10% upside, Red = >10% downside vs $109.50.
Pre-computed DCF: WACC=7.8%, terminal growth 3%. Fair value $351 (+201.5%). Not investment advice.
Valuation Context
Currently trading 48% above its 5-year average P/E of 12.7x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedThe stock is trading below its 50-day moving average but significantly above the 200-day moving average, indicating a recent pullback in an overall upward trend. The RSI at 45.8 suggests that near-term momentum may be neutral to slightly bearish, implying potential for consolidation or mild downward pressure.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-05-27 | $0.2600 | 0.0% |
| 2026-03-03 | $0.2600 | +4.0% |
| 2025-11-26 | $0.2500 | 0.0% |
| 2025-09-04 | $0.2500 | 0.0% |
| 2025-05-27 | $0.2500 | 0.0% |
| 2025-03-04 | $0.2500 | 0.0% |
| 2024-11-27 | $0.2500 | 0.0% |
| 2024-09-05 | $0.2500 | 0.0% |
| 2024-06-04 | $0.2500 | 0.0% |
| 2024-03-04 | $0.2500 | -37.5% |
| 2023-11-29 | $0.4000 | 0.0% |
| 2023-09-06 | $0.4000 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
10-K Risk Factor Expansion
Word count of Item 1A (Risk Factors) across annual filings. Rising counts often signal new regulatory, competitive, or operational risks.
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like IYM or GDX, the fund manager is mechanically forced to buy or sell NEM shares regardless of Newmont Corporation's individual fundamentals. We estimate $18.0B of passive capital is structurally linked to NEM through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Newmont Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If Newmont Corporation (NEM) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Linde PLC (LIN) as the most exposed collateral stock, sharing 1 ETFs with NEM. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 40 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
NEM Ownership Dynamics
Passive funds hold 1 in every 6 NEM shares, reducing daily market volatility.
Newmont Corporation (NEM) exerts notable gravity on the passive index market, currently representing 10.5% of the IYM (IYM) and 8.8% of the VanEck Gold Miners ETF (GDX). Across 39 tracked ETFs, approximately 172M shares (16.1% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest NEM Exposure
Float lock-up computed from 39 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
NEM Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Newmont Corporation over the past year sits near $57.88 (12% of 252-day volume). The current price of $109.50 trades 89.2% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (12% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
NEM Capital Efficiency
How efficiently does Newmont Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Newmont Corporation converts 52% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 9.9% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-11 | 400 | $116.51 | $46,604 |
| 2026-05-05 | 44,443 | $108.33 | $4.8M |
| 2026-04-27 | 11,044 | $120.70 | $1.3M |
| 2026-04-22 | 20 | $109.30 | $2,186 |
| 2026-04-21 | 466 | $114.84 | $53,515.44 |
| 2026-04-20 | 3,020 | $116.50 | $351,830 |
| 2026-04-15 | 9 | $119.30 | $1,073.7 |
| 2026-04-10 | 100 | $119.01 | $11,901 |
| 2026-04-06 | 600 | $114.05 | $68,430 |
| 2026-03-25 | 38,880 | $99.02 | $3.8M |
| 2026-03-24 | 171 | $98.14 | $16,781.94 |
| 2026-03-23 | 1,200 | $95.80 | $114,960 |
| 2026-03-18 | 55 | $111.04 | $6,107.2 |
| 2026-03-03 | 6,267 | $128.73 | $806,750.91 |
| 2026-03-02 | 2,795 | $130.00 | $363,350 |
| 2026-02-27 | 332 | $127.47 | $42,320.04 |
| 2026-02-26 | 1,000 | $124.85 | $124,850 |
| 2026-02-25 | 1,017 | $124.09 | $126,199.53 |
| 2026-02-23 | 4,051 | $122.13 | $494,748.63 |
| 2026-02-19 | 1,622 | $124.69 | $202,247.18 |
| 2026-02-18 | 100 | $122.31 | $12,231 |
| 2026-02-17 | 1,600 | $125.80 | $201,280 |
| 2026-02-10 | 1,664 | $120.73 | $200,894.72 |
| 2026-02-09 | 700 | $115.32 | $80,724 |
| 2026-02-02 | 100 | $112.35 | $11,235 |
| 2026-01-29 | 216 | $131.95 | $28,501.2 |
| 2026-01-28 | 416 | $127.00 | $52,832 |
| 2026-01-27 | 1,860 | $125.92 | $234,211.2 |
| 2026-01-26 | 1,200 | $124.31 | $149,172 |
| 2026-01-23 | 23,610 | $121.69 | $2.9M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
SEC Comment Letters
SEC correspondence with the company regarding their filings. Comment letters often flag disclosure deficiencies, accounting concerns, or material omissions.
Source: SEC EDGAR correspondence. Comment letters are public records of SEC staff review of company filings.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| GFI | 0.834 | 0.894 | High co-movement |
| GB00BRXH2664 | 0.817 | 0.849 | High co-movement |
| AU | 0.817 | 0.849 | High co-movement |
| RGLD | 0.796 | 0.830 | High co-movement |
| GB00BL6K5J42 | 0.735 | 0.748 | High co-movement |
| HL | 0.666 | 0.785 | Moderate |
| CDE | 0.659 | 0.789 | Moderate |
| GB00B2QPKJ12 | 0.647 | 0.677 | Moderate |
| MXP554091415 | 0.532 | 0.605 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare NEM to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.